We investigated the applicability of linear quadratic Gaussian (LQG) methodology to the subcutaneous blood glucose regulation problem. We designed an LQG-based feedback control algorithm using linearization of a previously published metabolic model of type 1 diabetes. A key feature of the controller is a Kalman filter used to estimate metabolic states of the patient based on continuous glucose monitoring. Insulin infusion is computed from linear quadratic regulator feedback gains applied to these estimates, generally seeking to minimize squared deviations from a target glucose concentration and basal insulin rate. We evaluated in silico subject-specific LQG control and compared it to preexisting proportional-integral-derivative control.
Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus. N Engl J Med. 1993 Sep 30; 329 (14): 977–86.
2.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes. Lancet. 1998 Sep 12; 352 (9131): 837–53.
3.
GoldAEFrierBMMacleodKMDearyIJ.A structural equation model for predictors of severe hypoglycemia in patients with insulin-dependent diabetes mellitus. Diabet Med. 1997 Apr; 14 (4): 309–15.
4.
CryerPE.Hypoglycemia is the limiting factor in the management of diabetes. Diabetes Metab Res Rev. 1999 Jan-Feb; 15 (1): 42–6.
5.
PfeifferEFThumCClemensAH.The artificial beta cell—a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). Horm Metab Res. 1974 Sep; 6 (5): 339–42.
6.
ClemensAH.Feedback control dynamics for glucose controlled insulin infusion system. Med Prog Technol1979 Jun 15; 6 (3): 91–8.
MarlissEBMurrayFTStokesEFZinmanBNakhoodaAFDenogaALeibelBSAlbisserAM.Normalization of glycemia in diabetics during meals with insulin and glucagon delivery by the artificial pancreas. Diabetes. 1977 Jul; 26 (7): 663–72.
9.
KraegenEWCampbellLVChiaYOMelerHLazarusL.Control of blood glucose in diabetics using an artificial pancreas. Aust N Z J Med. 1977 Jun; 7 (3): 280–6.
10.
FischerUJutziEFreyseEJSalzsiederE.Derivation and experimental proof of a new algorithm for the artificial B-cell based on the individual analysis of the physiological insulin-glucose relationship. Endokrinologie. 1978 Feb; 71 (1): 65–75.
11.
BroekhuyseHMNelsonJDZinmanBAlbisserAM.Comparison of algorithms for the closed-loop control of blood glucose using the artificial beta cell. IEEE Trans Biomed Eng. 1981 Oct; 28 (10): 678–87.
12.
SalzsiederEAlbrechtGFischerUFreyseEJ.Kinetic modeling of t he gluc or eg ulatory system to improve in sulintherapy. IEEE Trans Biomed Eng. 1985 Oct; 32 (10): 846–55.
13.
FischerUSchenkWSalzsiederEAlbrechtGAbelPFreyseEJ.Does physiological blood glucose control require an adaptive strategy?IEEE Trans Biomed Eng. 1987 Aug; 34 (8): 575–82.
14.
SorensenJT.A physiologic model of glucose metabolism in man and its use to design and assess improved insulin therapies for diabetes [dissertation]. Department of Chemical Engineering, MIT; 1985.
15.
KienitzKHYoneyamaT.A robust controller for insulin pumps based on H-infinity theory. IEEE Trans Biomed Eng. 1993 Nov; 40 (11): 1133–7.
16.
SwanGW.An optimal control model of diabetes mellitus. Bull Math Biol. 1982;44 (6): 793–808.
17.
FisherMETeoKL.Optimal insulin infusion resulting from a mathematical model of blood glucose dynamics. IEEE Trans Biomed Eng. 1989 Apr; 36 (4): 479–86.
18.
OllertonRL.Application of optimal control theory to diabetes mellitus. Int J Control. 1989;50: 2503–22.
19.
FisherME.A semiclosed-loop algorithm for the control of blood glucose levels in diabetics. IEEE Trans Biomed Eng. 1991 Jan; 38 (1): 57–61.
20.
ParrishDKRidgelyDB.Control of an artificial human pancreas using the SDRE method. Proceedings of American Control Conference, Albuquerque, NM; 1997. p. 1059–60.
21.
ParkerRSDoyleFJIIIPeppasNA.A model-based algorithm for blood glucose control in type I diabetic patients. IEEE Trans Biomed Eng. 1999 Feb; 46 (2): 148–57.
22.
MagniLRaimondoDMDalla ManCDe NicolaoGKovatchevBCobelliC.Model predictive control of glucose concentration in subjects with type 1 diabetes: an in-silico trial. Proceeding of IFAC World Congress (to appear); 2008 July; Seoul, Korea.
23.
BequetteBW.A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. Diabetes Technol Ther. 2005 Feb; 7 (1): 28–47.
24.
BoyneMSilverDKaplanJSaudekC.Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes. 2003 Nov; 52 (11): 2790–4.
CheyneEHCavanDAKerrD.Performance of continuous glucose monitoring system during controlled hypoglycemia in healthy volunteers. Diabetes Technol Ther. 2002;4 (5): 607–13.
27.
StoutPJRacchiniJRHilgersME.A novel approach to mitigating the physiological lag between blood and interstitial fluid glucose measurements. Diabetes Technol Ther. 2004 Oct; 6 (5): 635–44.
28.
KulcuETamadaJAReachGPottsROLeshoMJ.Physiological differences between interstitial glucose and blood glucose measured in human subjects. Diabetes Care. 2003 Aug; 26 (8): 2405–9.
29.
ClarkeWLCoxDGonder-FrederickLACarterWPohlSL.Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care. 1987 Sep-Oct; 10 (5): 622–8.
International Organisation for Standardization. In vitro diagnostic test systems: requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. Geneva, ISO; 2003 (no. 15197).
32.
KovatchevBPGonder-FrederickLACoxDJClarkeWL.Evaluating the accuracy of continuous glucose monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data. Diabetes Care. 2004 Aug; 27 (8): 1922–8.
33.
ClarkeWLAndersonSFarhyLBretonMGonder-FrederickLACoxDKovatchevB.Evaluating the clinical accuracy of two continuous glucose sensors using continuous glucose-error grid analysis. Diabetes Care. 2005 Oct; 28 (10): 2412–7.
34.
LeblancHChauvetDLombrailPRobertJJ.Glycemic control with closed-loop intraperitoneal insulin in type I diabetes. Diabetes Care. 1986 Mar-Apr; 9 (2): 124–8.
35.
SelamJLMicossiPDunnFLNathanDM.Clinical trial of programmable implantable insulin pump for type I diabetes. Diabetes Care. 1992 Jul; 15 (7): 877–85.
36.
RenardE.Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy. Curr Opin Pharmacol. 2002 Dec; 2 (6): 708–16.
HovorkaRCanonicoVChassinLJHaueterUMassi-BenedettiMFedericiM OrsiniPieberTRSchallerHCSchauppLVeringTWilinskaME.Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiol Meas. Aug; 25 (4): 905–20.
39.
El-KhatibFHJiangJDamianoER.Adaptive closed-loop control provides blood-glucose regulation using dual subcutaneous insulin and glucagon infusion in diabetic swine. J Diabetes Sci Technol. 2007 Mar; 1 (2): 181–92.
40.
SteilGMRebrinKDarwinCHaririFSaadMF.Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes. 2006 Dec; 55 (12): 3344–50.
41.
AndersonBDMooreJB.Optimal control: linear quadratic methods. Englewood Cliffs (NJ): Prentice-Hall; 1989.
42.
Dalla ManCRizzaRACobelliC.Meal simulation model of the glucose-insulin system. IEEE Trans Biomed Eng. 2007 Oct; 54 (10): 1740–9.
43.
Dalla ManCRaimondoDMRizzaRACobelliC.GIM, simulation software of meal glucose-insulin model. J Diabetes SciTechnol. 2007 May; 1 (3): 323–30.
44.
KovatchevBPCoxDJGonder-FrederickLAClarkeWL.Symmetrization of the blood glucose measurement scale and its applications. Diabetes Care. 1997 Nov; 20 (11): 1655–8.
45.
BergmanRNIderYZBowdenCRCobelliC.Quantitative estimation of insulin sensitivity. Am J Physiol. 1979 Jun; 236 (6): E667–77.
